The bovine segment by source is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Source, Product, Application and Country.” The North America medical collagen market is expected to reach US$ 441.84 million in 2028 from US$ 285.22 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The report highlights trends prevailing in the North America medical collagen market and the factors driving market along with those that act as hindrances. 

As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications. Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Moreover, collagen fillers are widely used in aesthetic medicines. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing dermatological defects. Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes for spine, extremities, and dental requirements. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair. Collagen is naturally involved in the wound-healing process, and the use of collagen-based wound dressing offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound either by absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds. This wide range of applications of collagen in the medical industry is driving the growth of the market. Various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and capacity to cater to a large customer base. Thus, constant advancements in products and approvals from regulatory bodies are factors further driving the growth of the medical collagen market.

As per the IRI data, demand for various dietary supplements increased at unprecedented rates owing to the onset of the COVID-19 pandemic in the US. The total supplement sales increased by 6% during the first week of March 2020. Also, due to social distancing practices, consumers are experiencing changes in their daily routines involving grooming and skincare. This has led to an increased demand for nutricosmetics that can be used at home. This is likely to favor the growth of skincare collagen products. Hence, COVID-19 has had a positive impact on the North America medical collagen market.

The North America medical collagen market, by source, is segmented into bovine, porcine, and others. The North America medical collagen market, by product, is segmented into gelatine, hydrolysed collagen, native collagen, and others. Based on application, the North America medical collagen market has been segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and other. Geographically, the North America medical collagen market can be sub-segmented into U.S. Mexico and Canada.

DSM, Collagen Solutions Plc, Innocoll Pharmaceuticals, ENCOLL Corp, CollPlant Biotechnology, GELITA AG, Collagen Matrix, Inc., Integra Life Sciences Corporation and Croda International plc are among the leading companies operating in the North America medical collagen market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com